Saverio,
that was after 5 days but then the virus levels rose again by the 20th day.
This is not a trend that looks attractive to me.
It is obvious to me that another HIV trial would need to be commissioned using bit2225 in a 90 day trial with the current standard of care drugs.
The question is whether a pharma would be willing to pay for this access at this point in time with the limited evidence we have.
now we know, page-8
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
